The upgrade from Sell to Neutral by Citigroup suggests a change in sentiment towards Illumina, potentially reducing selling pressure and encouraging investors. The increase in price target to $120 reflects a more optimistic valuation of the company's prospects, which could lead to a short-term increase in the stock price as the market digests this new information.